US FDA Approves New Monoclonal Antibody That is Effective Against Omicron Variant
The Food and Drug Administration (FDA) of the United States have given the authorization for a new monoclonal antibody treatment that is working effectively against the Omicron covid-19 variant. The emergency use authorization for the bebtelovimab has been for the treatment of the mild to moderate corona virus in the adults and pediatric patients around […]
Continue Reading